| Micro Test 1 |
Micro Test 1 |
Unfinished |
2020-03-05 |
mdf15 |
124 |
0 |
edit |
|
| Head,Ears,Eyes,Nose |
BenchmarkDrugReview |
Unfinished |
2022-08-21 |
mdf15 |
47 |
1 |
edit |
|
| InfectiousViralAgent |
InfectiousViralAgent |
Unfinished |
2019-03-25 |
mdf15 |
73 |
0 |
edit |
|
| Ceutic 4 Final Part1 |
Pharmaceutic 4 Final |
Unfinished |
2020-02-26 |
mdf15 |
105 |
0 |
edit |
|
| Ceutic 4 Final Part2 |
Ceutic 4 Final Part2 |
Unfinished |
2020-02-26 |
mdf15 |
113 |
0 |
edit |
|
| Neuro&Physchiatric |
BenchmarkDrugReview |
Unfinished |
2021-05-12 |
mdf15 |
65 |
2 |
edit |
|
| Pulmonary Drugs |
BenchmarkDrugReview |
Unfinished |
2020-09-14 |
mdf15 |
14 |
1 |
edit |
|
| PHCS Exam 1 |
PHCS Exam 1 |
Unfinished |
2019-04-03 |
mdf15 |
44 |
0 |
edit |
|
| Intro to Immunity |
Micro Test 3 |
Unfinished |
2019-10-13 |
mdf15 |
74 |
0 |
edit |
|
| Running Drug List |
BenchmarkDrugReview |
Unfinished |
2020-02-03 |
mdf15 |
50 |
1 |
edit |
|
| Infectious Diseases |
BenchmarkDrugReview |
Unfinished |
2021-04-19 |
mdf15 |
40 |
1 |
edit |
|
| Endocrine |
BenchmarkDrugReview |
Unfinished |
2020-09-27 |
mdf15 |
40 |
1 |
edit |
|
| InnateImmuneSystem1 |
Micro Test 3 |
Unfinished |
2019-10-13 |
mdf15 |
38 |
0 |
edit |
|
| InnateImmuneSystem2 |
Micro Test 3 |
Unfinished |
2019-10-13 |
mdf15 |
20 |
0 |
edit |
|
| AdaptiveImmune1 |
Micro Test 3 |
Unfinished |
2019-10-13 |
mdf15 |
26 |
0 |
edit |
|
| AdaptiveImmune2 |
Micro Test 3 |
Unfinished |
2019-10-13 |
mdf15 |
27 |
0 |
edit |
|
| AdaptiveImmune3 |
Micro Test 3 |
Unfinished |
2019-10-13 |
mdf15 |
28 |
0 |
edit |
|
| Cardiovasc Disease |
BenchmarkDrugReview |
Unfinished |
2020-02-10 |
mdf15 |
69 |
0 |
edit |
|
| Musculoskeletal |
BenchmarkDrugReview |
Unfinished |
2020-03-02 |
mdf15 |
23 |
0 |
edit |
|
| A.I TCell Activation |
Micro Test 4 |
Unfinished |
2019-04-27 |
mdf15 |
29 |
0 |
edit |
|
| A.I T&B cell Activa |
Micro Test 4 |
Unfinished |
2019-04-29 |
mdf15 |
21 |
0 |
edit |
|
| Cancer immunology |
Micro Test 4 |
Unfinished |
2019-05-02 |
mdf15 |
44 |
0 |
edit |
|
| Schedule 1-5 Drugs |
Pharmacy Tech Test |
Unfinished |
2019-10-13 |
mdf15 |
31 |
1 |
edit |
|
| Gastrointestinal |
BenchmarkDrugReview |
Unfinished |
2019-10-13 |
mdf15 |
24 |
1 |
edit |
|
| Pharmacy Tech Review |
PTCE |
Unfinished |
2021-09-08 |
mdf15 |
166 |
2 |
edit |
|
| Pain,Hemato,Oncology |
BenchmarkDrugReview |
Unfinished |
2019-07-09 |
mdf15 |
21 |
0 |
edit |
|
| DAW |
Pharmacy Tech Test |
Unfinished |
2019-10-13 |
mdf15 |
10 |
1 |
edit |
|
| Pharmacokinetic |
Exam 1 |
Unfinished |
2019-08-24 |
mdf15 |
17 |
0 |
edit |
|
| P2 Drug Quiz 1 |
With Side effects |
Unfinished |
2019-09-02 |
mdf15 |
29 |
0 |
edit |
|
| P2 Drug Quiz 2 |
With Side effects |
Unfinished |
2019-09-04 |
mdf15 |
33 |
0 |
edit |
|
| P2 Drug Quiz 3 |
With Side effects Neuro 1-2 |
Unfinished |
2019-09-17 |
mdf15 |
30 |
0 |
edit |
|
| P2 Drug Quiz 4 |
With Side effects Neuro 3-5 |
Unfinished |
2019-09-29 |
mdf15 |
24 |
0 |
edit |
|
| Lecture 1 |
Pharmacology Exam 1 |
Unfinished |
2019-09-29 |
mdf15 |
49 |
0 |
edit |
|
| P2 Drug Quiz 5 |
With Side effects Head/Ears/Eyes/Nose/Throat & Renal |
Unfinished |
2020-02-09 |
mdf15 |
46 |
0 |
edit |
|
| Exam 2 |
Pharmacokinetics |
Unfinished |
2019-09-29 |
mdf15 |
39 |
0 |
edit |
|
| G-Protein |
Pharmacology Exam 1 |
Unfinished |
2020-10-11 |
mdf15 |
7 |
1 |
edit |
|
| P2 Drug Quiz 6 |
With Side effects cardio 1-4 |
Unfinished |
2019-10-07 |
mdf15 |
33 |
0 |
edit |
|
| Drugs, SOA, MOA |
Pharmacology Exam 2 |
Unfinished |
2020-10-11 |
mdf15 |
20 |
1 |
edit |
|
| P2 Drug Quiz 7 |
pulmonary and Endocrine w/ Side effects |
Unfinished |
2019-10-28 |
mdf15 |
47 |
0 |
edit |
|
| Exam 3 |
Pharmacokinetics |
Unfinished |
2019-10-27 |
mdf15 |
29 |
0 |
edit |
|
| Drug Intractions |
Pharmacology Exam 4 |
Unfinished |
2019-10-31 |
mdf15 |
66 |
0 |
edit |
|
| P2 Drug Quiz 8 |
GI and Pain, Hematology, & Oncology |
Unfinished |
2019-11-11 |
mdf15 |
45 |
0 |
edit |
|
| Atopic Dermatitis |
DEENT Exam 3 |
Unfinished |
2019-11-21 |
mdf15 |
30 |
0 |
edit |
|
| Psoriasis |
DEENT Exam 3 |
Unfinished |
2019-11-19 |
mdf15 |
22 |
0 |
edit |
|
| Acne |
DEENT Exam 3 |
Unfinished |
2019-11-19 |
mdf15 |
14 |
0 |
edit |
|
| Drugss |
DEENT Exam 3 |
Unfinished |
2019-12-01 |
mdf15 |
54 |
0 |
edit |
|
| Outdoor Exposure |
DEENT Exam 4 |
Unfinished |
2019-12-07 |
mdf15 |
86 |
0 |
edit |
|
| Wound Care |
DEENT Exam 4 |
Unfinished |
2019-12-07 |
mdf15 |
21 |
0 |
edit |
|
| Acne |
DEENT Exam 4 |
Unfinished |
2019-12-07 |
mdf15 |
21 |
0 |
edit |
|
| Fluid & Electrolytes |
PT 4 - Renal Disorder |
Unfinished |
2020-01-19 |
mdf15 |
163 |
0 |
edit |
|
| Exam 2 |
PT 4 - Renal Disorder |
Unfinished |
2020-01-29 |
mdf15 |
13 |
0 |
edit |
|
| Exam 3 |
PT 4 - Renal Disorder |
Unfinished |
2020-01-30 |
mdf15 |
52 |
0 |
edit |
|
| Exam 3 Drugs |
PT 4 - Renal Disorder |
Unfinished |
2020-01-30 |
mdf15 |
8 |
0 |
edit |
|
| HTN Receptors & SOA |
HTN Receptors & SOA |
Unfinished |
2020-02-12 |
mdf15 |
12 |
0 |
edit |
|
| Running Drug List |
Top 300 with Side Effects |
Unfinished |
2020-02-23 |
mdf15 |
82 |
0 |
edit |
|
| IschemicHeartDisease |
PT5 Cario |
Unfinished |
2020-02-27 |
mdf15 |
21 |
0 |
edit |
|
| Neuro w/ Side effect |
Neuro w/ Side effect |
Unfinished |
2020-03-31 |
mdf15 |
30 |
0 |
edit |
|
| Final Drug Quiz |
P2 with side effects |
Unfinished |
2020-04-20 |
mdf15 |
14 |
0 |
edit |
|
| Renal |
BenchmarkDrugReview |
Unfinished |
2021-04-11 |
mdf15 |
14 |
0 |
edit |
|
| ID Exam 1 Disease |
ID |
Unfinished |
2020-09-02 |
mdf15 |
19 |
0 |
edit |
|
| Quiz 2 |
Skeletal & Muscular Disease |
Unfinished |
2020-09-03 |
mdf15 |
16 |
0 |
edit |
|
| Quiz 3 |
Skeletal & Muscular Disease |
Unfinished |
2020-09-09 |
mdf15 |
9 |
0 |
edit |
|
| Diabetes Drugs |
Endocrine |
Unfinished |
2020-12-06 |
mdf15 |
36 |
0 |
edit |
|
| Sexual Disorders |
Endocrine |
Unfinished |
2020-12-06 |
mdf15 |
11 |
0 |
edit |
|
| T1Effects of Agonist |
CNS |
Unfinished |
2021-01-04 |
mdf15 |
6 |
0 |
edit |
|
| P3 Benchmark Prep |
Benchmark Prep |
Unfinished |
2021-01-10 |
mdf15 |
15 |
0 |
edit |
|
| E1 Drugs |
CNS |
Unfinished |
2021-01-13 |
mdf15 |
21 |
0 |
edit |
|
| E2 Anxiety Treatment |
CNS |
Unfinished |
2021-01-21 |
mdf15 |
5 |
0 |
edit |
|
| E2 SSRI Drugs |
CNS |
Unfinished |
2021-01-21 |
mdf15 |
5 |
0 |
edit |
|
| E2 Drug Pharm & Med |
CNS |
Unfinished |
2021-01-21 |
mdf15 |
15 |
0 |
edit |
|
| E2 Insomnia Drugs |
CNS |
Unfinished |
2021-01-22 |
mdf15 |
11 |
0 |
edit |
|
| E3 Epilepsy Drugs |
CNS |
Unfinished |
2021-01-27 |
mdf15 |
10 |
0 |
edit |
|
| E3 ADHD |
CNS |
Unfinished |
2021-01-28 |
mdf15 |
20 |
0 |
edit |
|
| E3 Drugs of Abuse |
CNS |
Unfinished |
2021-01-27 |
mdf15 |
15 |
0 |
edit |
|
| E4 Side Effects |
CNS |
Unfinished |
2021-02-04 |
mdf15 |
8 |
0 |
edit |
|
| E4 MMD |
CNS |
Unfinished |
2021-02-04 |
mdf15 |
28 |
0 |
edit |
|
| E5 Dementia Drugs |
CNS |
Unfinished |
2021-02-11 |
mdf15 |
5 |
0 |
edit |
|
| E5 ParkinsonsD Drugs |
CNS |
Unfinished |
2021-02-12 |
mdf15 |
18 |
0 |
edit |
|
| E6 Schizophrenia ADR |
CNS |
Unfinished |
2021-02-25 |
mdf15 |
10 |
0 |
edit |
|
| E6 Schizophrenia Dru |
CNS |
Unfinished |
2021-02-25 |
mdf15 |
19 |
0 |
edit |
|
| E2 Const/Diarrhea |
GI |
Unfinished |
2021-03-15 |
mdf15 |
21 |
0 |
edit |
|
| E2 IBD Brand & Form |
GI |
Unfinished |
2021-03-16 |
mdf15 |
12 |
0 |
edit |
|
| Basic PharmEconomics |
Economics |
Unfinished |
2021-03-17 |
mdf15 |
10 |
0 |
edit |
|
| E3 HCV Drugs |
GI |
Unfinished |
2021-03-21 |
mdf15 |
11 |
0 |
edit |
|
| FINAL BENCHMARK |
Benchmark Prep |
Unfinished |
2022-04-07 |
mdf15 |
336 |
2 |
edit |
|
| E2 Iron Products |
Oncology |
Unfinished |
2021-04-10 |
mdf15 |
12 |
0 |
edit |
|
| E2 Thrombocytopenia |
Oncology |
Unfinished |
2021-04-11 |
mdf15 |
13 |
0 |
edit |
|
| E2 Neutropenia |
Oncology |
Unfinished |
2021-04-11 |
mdf15 |
15 |
0 |
edit |
|
| E2 Smith Drugs |
Oncology |
Unfinished |
2022-04-01 |
mdf15 |
12 |
1 |
edit |
|
| Final Onco MedChem |
Oncology |
Unfinished |
2021-04-30 |
mdf15 |
30 |
0 |
edit |
|
| Lung Cancer Mutation |
Oncology |
Unfinished |
2021-04-28 |
mdf15 |
8 |
0 |
edit |
|
| HIV Drug |
Seminar |
Unfinished |
2022-04-13 |
mdf15 |
16 |
0 |
edit |
|
| HIV Combo Drugs |
Seminar |
Unfinished |
2022-04-13 |
mdf15 |
11 |
0 |
edit |
|
